ASH Clinical News ACN_4.6_Full_Issue_web | Page 72

Drug Importation In 2013, Maine passed a law legalizing the purchase of prescription medication by mail from other countries, but a federal judge struck this down in 2015. 17 “The federal court ruled that the law passed in Maine violated federal law in a space where federal law is preemptive over state law,” Dr. McCall explained. “The concern was that if states are allowed to preempt federal law and indi- vidually have standards for prescription drugs, we would end up with 50 differ- ent standards, a deregulated drug supply chain, and compromised patient safety.” According to Dr. McCall, individuals in Maine could buy prescriptions drugs via mail from Canada, the U.K., Australia, and New Zealand. To gain firsthand experience with these by-mail pharmacies, Dr. McCall (who was serving as president of the Maine Pharmacy Association at the time) ordered some of the branded prescription products advertised in local papers, including Viagra® (sildenafil), Plavix® (clopidogrel), Prilosec® (omeprazole), and Celebrex® (celecoxib). “All four of the products sent were not FDA-approved and not Canada Health–approved,” Dr. McCall said. For example, the Viagra product was called Fildena, which is not available in the U.S. or Canada. “Legislators were trying to do what they thought was right by putting in place some safety parameters,” he said. “The problem is that there were no regulations in place to ensure that the products being sold weren’t [imported to Canadian phar- macies] from Turkey or India.” In January, Vermont was consider- ing legislation to legalize the importation of drugs from Canada, and a Utah bill called on the state’s Department of Health to study and report on prescription drug